Meeder Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,246
Closed -$16K 1770
2022
Q3
$16K Sell
1,246
-336
-21% -$4.96K ﹤0.01% 1176
2022
Q2
$22K Sell
1,582
-444
-22% -$5.94K ﹤0.01% 1114
2022
Q1
$30K Buy
+2,026
New +$27.7K ﹤0.01% 1127
2021
Q4
Sell
-466
Closed -$7K 2122
2021
Q3
$7K Buy
466
+199
+75% +$3.36K ﹤0.01% 1814
2021
Q2
$5K Sell
267
-4,789
-95% -$85.3K ﹤0.01% 1968
2021
Q1
$88K Buy
5,056
+4,938
+4,185% +$86.8K ﹤0.01% 945
2020
Q4
$2K Buy
+118
New +$1.88K ﹤0.01% 1528
2017
Q4
Sell
-1,351
Closed -$30K 1781
2017
Q3
$30K Sell
1,351
-2,588
-66% -$58.5K ﹤0.01% 793
2017
Q2
$95K Buy
3,939
+3,062
+349% +$77.9K 0.01% 568
2017
Q1
$24K Buy
877
+728
+489% +$19.1K ﹤0.01% 706
2016
Q4
$4K Buy
+149
New +$3.42K ﹤0.01% 882

Other funds holding SBRA

Meeder Asset Management's SBRA Position: Q4 2022 in Review

Meeder Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 1,246 shares — an estimated $16K sold.

Meeder Asset Management first reported a position in SBRA in Q4 2016 and held it in 11 quarters. The position peaked at $95K in Q2 2017. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Meeder Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 1,246 Sabra Healthcare REIT shares in Q4 2022, an estimated $16K.
  • Meeder Asset Management first reported a position in Sabra Healthcare REIT in Q4 2016 and held it in 11 quarters.
  • Meeder Asset Management's Sabra Healthcare REIT position peaked at $95K in Q2 2017.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.